Outcome of lower-risk myelodysplastic syndrome with ring sideroblasts (MDS-RS) after failure of erythropoiesis- stimulating agents

被引：3

作者：

Park, Sophie ^{[1
]}

Hamel, Jean-Francois ^{[2
]}

Toma, Andrea ^{[3
]}

Kelaidi, Charikleia ^{[4
]}

Thepot, Sylvain ^{[5
]}

Diez Campelo, Maria ^{[6
]}

Santini, Valeria ^{[7
]}

Sekeres, Mikkael A. ^{[8
]}

Komrokji, Rami ^{[9
]}

Steensma, David ^{[10
]}

Balleari, Enrico ^{[11
]}

Goetze, Katharina S. ^{[12
]}

Kotsianidis, Ioannis ^{[13
]}

Guerci-Bresler, Agnes ^{[14
]}

Stamatoullas, Aspasia ^{[15
]}

Sanz, Guillermo F. ^{[16
]}

Germing, Ulrich ^{[17
]}

Fenaux, Pierre ^{[18
,19
]}

机构：

[1] Univ Grenoble Alpes, CHU Grenoble Alpes, Inst Adv Biosci, Serv Hematol,CNRS,INSERM,UMR 5309,U1209, CS 10217, F-38043 Grenoble 09, France

[2] CHU Angers, Angers, France

[3] Hop Univ Henri Mondor, AP HP, Hematol DMU Geriatrie, Paris, France

[4] Aghia Sophia Childrens Hosp, Dept Pediat Hematol & Oncol, Athens, Greece

[5] Univ Angers, CHU Angers, INSERM, Unit 1232,LabEx IGO, Angers, France

[6] GESMD, Hosp Univ Salamanca, Salamanca, Spain

[7] Univ Florence, AOU Careggi, Hematol Unit, Florence, Italy

[8] Univ Miami, Div Hematol, Sylvester Comprehens Canc Ctr, Miami, FL USA

[9] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[10] Dana Farber Canc Inst, Boston, MA 02115 USA

[11] Univ Genoa, Osped Imperia ASL1, Med Interna, Ematol Oncol Med Interna Clin Traslaz, Imperiese Via S Agata 57, Genoa, Italy

[12] Tech Univ Munich, Dept Med 3, Klinikum Rechts Isar, Munich, Germany

[13] Democritus Univ Thrace, Dept Hematol, Univ Hosp Alexandroupolis, Alexandroupolis, Greece

[14] CHU Nancy, Nancy, France

[15] Ctr Henri Becquerel CHB, Rouen, France

[16] GESMD, Hosp Univ Salamanca, Salamanca, Spain

[17] Heinrich Heine Univ Dusseldorf, Univ Klinikum, Dept Hematol Oncol & Clin Immunol, Dusseldorf, Germany

[18] Hop St Louis, AP HP, Paris, France

[19] Univ Paris, Paris, France

来源：

LEUKEMIA RESEARCH | 2020年 / 99卷

关键词：

LENALIDOMIDE; SURVIVAL; TRIAL;

D O I：

10.1016/j.leukres.2020.106472

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：3

共 13 条

[1] Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes [J].

Fenaux, Pierre ;

Platzbecker, Uwe ;

Mufti, Ghulam J. ;

Garcia-Manero, Guillermo ;

Buckstein, Rena ;

Santini, Valeria ;

Diez-Campelo, Maria ;

Finelli, Carlo ;

Cazzola, Mario ;

Ilhan, Osman ;

Sekeres, Mikkael A. ;

Falantes, Jose F. ;

Arrizabalaga, Beatriz ;

Salvi, Flavia ;

Giai, Valentina ;

Vyas, Paresh ;

Bowen, David ;

Selleslag, Dominik ;

DeZern, Amy E. ;

Jurcic, Joseph G. ;

Germing, Ulrich ;

Goetze, Katharina S. ;

Quesnel, Bruno ;

Beyne-Rauzy, Odile ;

Cluzeau, Thomas ;

Voso, Maria-Teresa ;

Mazure, Dominiek ;

Vellenga, Edo ;

Greenberg, Peter L. ;

Hellstrom-Lindberg, Eva ;

Zeidan, Amer M. ;

Ades, Lionel ;

Verma, Amit ;

Savona, Michael R. ;

Laadem, Abderrahmane ;

Benzohra, Aziz ;

Zhang, Jennie ;

Rampersad, Anita ;

Dunshee, Diana R. ;

Linde, Peter G. ;

Sherman, Matthew L. ;

Komrokji, Rami S. ;

List, Alan F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (02) :140-151

[2] International scoring system for evaluating prognosis in myelodysplastic syndromes [J].

Greenberg, P ;

Cox, C ;

LeBeau, MM ;

Fenaux, P ;

Morel, P ;

Sanz, G ;

Sanz, M ;

Vallespi, T ;

Hamblin, T ;

Oscier, D ;

Ohyashiki, K ;

Toyama, K ;

Aul, C ;

Mufti, G ;

Bennett, J .

BLOOD, 1997, 89 (06) :2079-2088

[3] Supportive care and use of hematopoietic growth factors in myelodysplastic syndromes [J].

Hellstrom-Lindberg, Eva ;

Malcovati, Luca .

SEMINARS IN HEMATOLOGY, 2008, 45 (01) :14-22

[4] Erythropoietin and granulocyte-colony stimulating factor treatment associated with improved survival in myelodysplastic syndrome [J].

Jadersten, Martin ;

Malcovati, Luca ;

Dybedal, Ingunn ;

Della Porta, Matteo Giovanni ;

Invernizzi, Rosangela ;

Montgomery, Scott M. ;

Pascutto, Cristiana ;

Porwit, Anna ;

Cazzola, Mario ;

Hellstrom-Lindberg, Eva .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3607-3613

[5] SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts [J].

Malcovati, Luca ;

Karimi, Mohsen ;

Papaemmanuil, Elli ;

Ambaglio, Ilaria ;

Jadersten, Martin ;

Jansson, Monika ;

Elena, Chiara ;

Galli, Anna ;

Walldin, Gunilla ;

Della Porta, Matteo G. ;

Raaschou-Jensen, Klas ;

Travaglino, Erica ;

Kallenbach, Klaus ;

Pietra, Daniela ;

Ljungstrom, Viktor ;

Conte, Simona ;

Boveri, Emanuela ;

Invernizzi, Rosangela ;

Rosenquist, Richard ;

Campbell, Peter J. ;

Cazzola, Mario ;

Lindberg, Eva Hellstrom .

BLOOD, 2015, 126 (02) :233-241

[6] Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF:: the GFM experience [J].

Park, Sophie ;

Grabar, Sophie ;

Kelaidi, Charikleia ;

Beyne-Rauzy, Odile ;

Picard, Francoise ;

Bardet, Valerie ;

Coiteux, Valerie ;

Leroux, Genevieve ;

Lepelley, Pascale ;

Daniel, Marie-Therese ;

Cheze, Stephane ;

Mahe, Beatrice ;

Ferrant, Augustin ;

Ravoet, Christophe ;

Escoffre-Barbe, Martine ;

Ades, Lionel ;

Vey, Norbert ;

Aljassern, Lina ;

Stamatoullas, Aspasia ;

Mannone, Lionel ;

Dombret, Herve ;

Bourgeois, Keith ;

Greenberg, Peter ;

Fenaux, Pierre ;

Dreyfus, Francois .

BLOOD, 2008, 111 (02) :574-582

[7] Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents [J].

Park, Sophie ;

Hamel, Jean-Francois ;

Toma, Andrea ;

Kelaidi, Charikleia ;

Thepot, Sylvain ;

Campelo, Maria Diez ;

Santini, Valeria ;

Sekeres, Mikkael A. ;

Balleari, Enrico ;

Kaivers, Jennifer ;

Sapena, Rosa ;

Goetze, Katharina ;

Mueller-Thomas, Catharina ;

Beyne-Rauzy, Odile ;

Stamatoullas, Aspasia ;

Kotsianidis, Ioannis ;

Komrokji, Rami ;

Steensma, David P. ;

Fensterl, Jaime ;

Roboz, Gail J. ;

Bernal, Teresa ;

Ramos, Fernando ;

Calabuig, Marisa ;

Guerci-Bresler, Agnes ;

Bordessoule, Dominique ;

Cony-Makhoul, Pascale ;

Cheze, Stephane ;

Wattel, Eric ;

Rose, Christian ;

Vey, Norbert ;

Gioia, Daniela ;

Ferrero, Dario ;

Gaidano, Gianluca ;

Cametti, Giovanni ;

Pane, Fabrizio ;

Sanna, Alessandro ;

Germing, Ulrich ;

Sanz, Guillermo F. ;

Dreyfus, Francois ;

Fenaux, Pierre .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (14) :1591-+

[8] Proposals for revised IWG 2018 hematological response criteria in patients with MDS included in clinical trials [J].

Platzbecker, U. ;

Fenaux, P. ;

Ades, L. ;

Giagounidis, A. ;

Santini, V. ;

van de Loosdrecht, A. A. ;

Bowen, D. ;

de Witte, T. ;

Garcia-Manero, G. ;

Hellstrom-Lindberg, E. ;

Germing, U. ;

Stauder, R. ;

Malcovati, L. ;

Sekeres, Mikkael A. ;

Steensma, David P. ;

Gloaguen, S. .

BLOOD, 2019, 133 (10) :1020-1030

[9] A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes [J].

Platzbecker, U. ;

Symeonidis, A. ;

Oliva, E. N. ;

Goede, J. S. ;

Delforge, M. ;

Mayer, J. ;

Slama, B. ;

Badre, S. ;

Gasal, E. ;

Mehta, B. ;

Franklin, J. .

LEUKEMIA, 2017, 31 (09) :1944-1950

[10] Luspatercept Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS): Long-Term Results from Phase 2 PACE-MDS Study [J].

Platzbecker, Uwe ;

Germing, Ulrich ;

Gotze, Katharina ;

Kiewe, Philipp ;

Wolff, Thomas ;

Mayer, Karin ;

Chromik, Joerg ;

Radsak, Markus ;

Donovan, Eileen ;

Wilson, Dawn M. ;

Zhang, Xiaosha ;

Laadem, Abderrahmane ;

Sherman, Matthew L. ;

Attie, Kenneth M. ;

Giagounidis, Aristoteles .

BLOOD, 2016, 128 (22)

← 1 2 →